两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ EFFECT - Notice of Effectiveness Filed: 2019-03-25 AccNo: 9999999995-19-000516 Size: 1 KB 网页链接
$OpGen(OPGN)$ EFFECT - Notice of Effectiveness Filed: 2019-03-21 AccNo: 9999999995-19-000483 Size: 1 KB 网页链接
$OpGen(OPGN)$ EFFECT - Notice of Effectiveness Filed: 2019-03-21 AccNo: 9999999995-19-000484 Size: 1 KB 网页链接
$OpGen(OPGN)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-03-15 AccNo: 0001079973-19-000143 Size: 927 KB 网页链接
$OpGen(OPGN)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-03-15 AccNo: 0001079973-19-000145 Size: 930 KB 网页链接
$OpGen(OPGN)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-03-13 AccNo: 0001079973-19-000135 Size: 970 KB 网页链接
$OpGen(OPGN)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2019-03-13 AccNo: 0001079973-19-000137 Size: 6 MB 网页链接
$OpGen(OPGN)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-03-01 AccNo: 0001079973-19-000111 Size: 888 KB 网页链接
$OpGen(OPGN)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-02-28 AccNo: 0001104659-19-011585 Size: 371 KB 网页链接
$OpGen(OPGN)$ 8-K - Current report Filed: 2019-02-26 AccNo: 0001079973-19-000099 Size: 187 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接